In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to VolitionRX (VNRX – Research Report),
Tag: NYSE MKT:VNRX
VolitionRX (VNRX) Receives a Buy from Oppenheimer
In a report released today, Mark Breidenbach from Oppenheimer maintained a Buy rating on VolitionRX (VNRX – Research Report), with
VolitionRX (VNRX) Receives a New Rating from a Top Analyst
In a report released yesterday, Jason McCarthy from Maxim Group assigned a Buy rating to VolitionRX (VNRX – Research Report),
A Director at VolitionRX is Exercising Options
Yesterday it was reported that a Director at VolitionRX (VNRX – Research Report), Guy Archibald Innes, exercised options to buy
The President & CEO of VolitionRX (NYSE MKT: VNRX) is Buying Shares
Yesterday, the President & CEO of VolitionRX (VNRX – Research Report), Cameron John Reynolds, bought shares of VNRX for $11K.
VolitionRX (VNRX) Gets a Buy Rating from Oppenheimer
In a report released yesterday, Mark Breidenbach from Oppenheimer assigned a Buy rating to VolitionRX (VNRX – Research Report), with
Maxim Group Issues a Buy Rating on VolitionRX (VNRX)
In a report released today, Jason McCarthy from Maxim Group assigned a Buy rating to VolitionRX (VNRX – Research Report),